Dr. Suham Alexander speaks to Dr. Bob Schroth in this third segment about hypophosphatasia (HPP) and the dental implications and management of patients with this condition. Children with HPP have some definite dental challenges. The developing teeth in these children lack cementum on the roots which leads to premature exfoliation. Additionally, large pulp chambers and […]
Dr. Cheryl Greenberg, a pediatrician and geneticist, speaks to Dr. Suham Alexander about the clinical history and manifestations of HPP in her unique patient population in Winnipeg, MB. HPP is over-represented in the Mennonite population in Manitoba due to a “founder” mutation. Highlights HPP is categorized by age of onset: perinatal, infant, juvenile, adult (systemic […]
Dr. Aviv Ouanounou returns to Oasis Discussions to speak about drug therapy during pregnancy. This presentation is based on an article authored by Drs. Aviv Ouanounou and Dan Haas, from the University of Toronto, in the British Dental Journal in 2016. The article was also selected by the Royal College of Dental Surgeons of Ontario […]
Highlights In the first segment of a 4-part series, Dr. Marc McKee introduces Oasis Discussions followers to a soft bone disease which also has a significant dental impact. Hypophosphatasia (HPP) is a very rare disease that has a prevalence of approximately 1:100,000 live births. Much progress has been made in recent years in understanding HPP, […]
The webinar is hosted by Dr. Tanya Gibson. The webinar explores the pathogenesis and risk factors of medication-related osteonecrosis of the jaw. As well, it looks at the recommended management strategies based on the clinical stage at the time of presentation. Participants will learn: the pathogenesis of MRONJ. risk factors for developing MRONJ. the clinical […]
Continuing our series of pharmacological topics, my conversation with Dr. Mark Donaldson was about premedication for dental procedures, in particular, about the management of orofacial infections with antimicrobials. It’s always a pleasure to host Dr. Donaldson on Oasis Discussions, and we hope that you will enjoy as well as benefit from this interview. I also would […]
It’s always an honour to meet with Dr. Mark Donaldson, Pharmacologist and senior Executive Director at Vizient Inc. Part of our monthly conversations, Mark spoke about the three drug classes that every dental professional should know: antimicrobials, analgesics, and local anesthetics. I hope you find the interview informative. Chiraz Guessaier, CDA Oasis Manager Highlights Oral […]
Drs. Deborah Saunders and Joel Epstein return to Oasis Discussions to discuss a third complication that occurs during cancer therapy and beyond, xerostomia. Xerostomia affects speech, chewing, swallowing, taste and overall nutrition which may negatively affect overall treatment and patient outcomes during therapy. Xerostomia is not related to aging as much as it reflects the […]